CO-DIOVAN 320/25 mg valsartan 320 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 320/25 mg valsartan 320 mg/hydrochlorothiazide 25 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 320 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; crospovidone; hypromellose; purified talc; iron oxide yellow; macrogol 4000; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 320/12.5 mg valsartan 320 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 320/12.5 mg valsartan 320 mg/hydrochlorothiazide 12.5 mg film-coated tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 320 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; microcrystalline cellulose; magnesium stearate; hypromellose; purified talc; iron oxide red; macrogol 4000; iron oxide black; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 160/25 valsartan 160 mg and hydrochlorothiazide 25 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 160 mg; hydrochlorothiazide, quantity: 25 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; colloidal anhydrous silica; hypromellose; purified talc; iron oxide yellow; macrogol 4000; iron oxide red; iron oxide black; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 160/12.5 valsartan 160 mg and hydrochlorothiazide 12.5 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: crospovidone; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide red; macrogol 8000; magnesium stearate; hypromellose; colloidal anhydrous silica - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

CO-DIOVAN 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

co-diovan 80/12.5 valsartan 80 mg and hydrochlorothiazide 12.5 mg tablet blister pack

novartis pharmaceuticals australia pty ltd - hydrochlorothiazide, quantity: 12.5 mg; valsartan, quantity: 80 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; iron oxide yellow; colloidal anhydrous silica; crospovidone; purified talc; magnesium stearate; hypromellose; macrogol 8000; iron oxide red; titanium dioxide - co-diovan is indicated for the treatment of hypertension. treatment should not be initiated with these combinations.

BIOLOGICAL THERAPIES METHYLCOBALAMIN 10mg/2mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

biological therapies methylcobalamin 10mg/2ml injection vial

orthomolecular medisearch laboratories pty ltd trading as biological therapies - mecobalamin, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections - cobalamin deficiency may exist that is unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of vitamin b12 may be insufficient in pernicious anaemia, malabsorption disorders, gastrectomy and gastrointestinal pathologies. specific indications may include: 1. pernicious anaemia as a result of in situ b12 deficiency. in pernicious anaemia co-methylcobalamin is disproportionately reduced in relation to other cobalamins. 2. as an adjunct to the treatment of peripheral neuropathies and diabetic polyneuropathy.

Bio-Rad Abbott Immunoassay-MCC (Liquid) Level 12 and 3 Singapore - English - HSA (Health Sciences Authority)

bio-rad abbott immunoassay-mcc (liquid) level 12 and 3

bio-rad laboratories (singapore) pte ltd - immunology - bio-rad abbott immunoassay-mcc (liquid) level 1,2 and 3 is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the analytes listed in the package insert.

Bio-Rad Abbott Tumor Marker-MCC (Lyphoilized) Levels 1 and 2 Singapore - English - HSA (Health Sciences Authority)

bio-rad abbott tumor marker-mcc (lyphoilized) levels 1 and 2

bio-rad laboratories (singapore) pte ltd - immunology - bio-rad abbott tumor marker-mcc (lyphoilized) levels 1 and 2 is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the analyst listed in the package insert.

Bio-Rad Antiserum Salmonella Omnivalent Omni-0 (A-60) Singapore - English - HSA (Health Sciences Authority)

bio-rad antiserum salmonella omnivalent omni-0 (a-60)

bio-rad laboratories (singapore) pte ltd - microbiology - agglutinating salmonella omni-o antiserum (a-60) allows the presumptive identification of o-agglutinable strains of salmonellaes belonging to groups a to 60 from colonies isolated on agar medium.

Bio-Rad Assayed Virotrol I-C I-E and I-F Singapore - English - HSA (Health Sciences Authority)

bio-rad assayed virotrol i-c i-e and i-f

bio-rad laboratories (singapore) pte ltd - microbiology - they are intended for use with in vitro assay procedures for determination of antibodies to human immunodeficiency virus type 1 (hiv-1), antibodies to human t-lymphotropic virus type i (htlv-i), antibodies to hepatitis c virus (hcv), hepatitis b surface antigen (hbsag), antibodies to hepatitis b core antigen (hbc) and antibodies to cytomegalovirus (cmv). this product is intended to provide a means of estimating precision and has the potential for detecting systematic deviations from specific laboratory testing procedures. bio-rad assayed virotrol i-c is most suitable for use with siemens advia® centaur® series; bio-rad assayed virotrol i-e is most suitable for use with roche elecsys®/modular systems; bio-rad assayed virotrol i-f is most suitable for use with abbott axsym® and architect™ systems.